Concepedia

Matt A. Tschantz

MA

Statistics

Publications

6

Citations

285

H-Index

6

Active since

1995

Affiliations

Boehringer Ingelheim (United States)(Current)

Matt A. Tschantz is an author at Boehringer Ingelheim (United States) specializing in medicinal chemistry, chemistry, and pharmacy.

Publications per year

1995–2003

6

Publications

6

Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 Selectivity

Edward S. Lazer, Clara K. Miao, Charles L. Cywin et al. · Journal of Medicinal Chemistry · 1997 · 93 citations · Full text

, , +14

Discovery of 2-Phenylamino-imidazo[4,5-<i>h</i>]isoquinolin-9-ones:  A New Class of Inhibitors of Lck Kinase

Roger J. Snow, Mario Cardozo, Tina M. Morwick et al. · Journal of Medicinal Chemistry · 2002 · 63 citations · Full text

, , +14

Optimization of 2-Phenylaminoimidazo[4,5-<i>h</i>]isoquinolin-9-ones:  Orally Active Inhibitors of lck Kinase

Daniel R. Goldberg, Tanja Butz, Mario Cardozo et al. · Journal of Medicinal Chemistry · 2003 · 45 citations · Full text

, , +12

Isoquinolinone synthesis by SNAr reaction: a versatile route to imidazo[4,5-h]isoquinolin-9-ones

Roger J. Snow, Tanja Butz, Abdelhakim Hammach et al. · Tetrahedron Letters · 2002 · 34 citations

, , +8

Asymmetric Lewis Acid-Catalyzed Addition of a Ketene Dithioacetal to a Chiral Bicyclic Lactam. Formation of Cyclobutanopyrrolidinones. A New Class of GABA Derivatives

A. I. MEYERS, Matt A. Tschantz, Gregory P. Brengel · The Journal of Organic Chemistry · 1995 · 32 citations

, , +17

1–5 of 6